Abu Dhabi Stem Cells Center and Yas Clinic first in UAE to receive AABB accreditation for haematopoietic progenitor cell collection
As a Centre of Excellence in Hematopoietic Stem Cell Transplantation, accredited by the Department of Health Abu Dhabi and an accredited facility by the Foundation of Accreditation for Cellular Therapy (FACT), ADSCC and Yas Clinic's AABB accreditation further reinforces their commitment to excellence in cellular therapy and solidifies their leadership in regenerative medicine. Earning these three accreditations for cellular therapies in only 24 months is a testament to their dedication to the highest standards of quality, safety, and innovation in patient care within their Abu Dhabi Bone Marrow Transplant Program and their fully-fledged CAR-T and Mesenchymal Stem Cells programmes.
Prof Yendry Ventura, Chief Executive Officer of ADSCC and Adjunct Professor at United Arab Emirates University, said: 'Under the visionary leadership of the UAE and in alignment with the national healthcare agenda, ADSCC and Yas Clinic remain dedicated to advancing cellular therapy and medical innovation on a global scale. Achieving AABB accreditation marks a significant milestone in our commitment to excellence in cellular therapies. As the first institution in the UAE to receive this prestigious accreditation, we continue to set new benchmarks in quality and patient safety which is backed by a solid infrastructure, a state-of-the-art apheresis and ECP unit, and unparalleled clinical expertise. This achievement underscores our dedication to pioneering cutting-edge treatments, enhancing healthcare standards, and reinforcing UAE's position as a regional leader in regenerative medicine and biological sciences.'
Dr Maysoon Al Karam, Chief Medical Officer at Yas Clinic operated by ADSCC , said: 'This achievement reflects the efforts and expertise of our entire team of scientists, haematologists, immunologists, nurses and technicians and beyond. Being one of only two AABB-accredited facilities in the MENA region for HPC collection is a significant milestone for our patients and also physicians, and we are proud to contribute to the advancement of cellular therapy in the UAE and beyond. This accreditation positions ADSCC and Yas Clinic as a regional leader in bone marrow transplant and cellular therapy and reinforces our role in providing cutting-edge treatments to patients.'
AABB's accreditation programme is the leader in ensuring the highest level of quality and safety for the blood and biotherapies field. AABB's accreditation programme promotes the highest standards of care for patients, donors, processes and products in all aspects of transfusion medicine, biotherapies and relationship testing.
About Abu Dhabi Stem Cells Center ADSCC:
Abu Dhabi Stem Cells Center (ADSCC) is a renowned healthcare institution in Abu Dhabi, UAE, specialising in advanced stem cell therapy, research, and regenerative medicine. ADSCC is the incubator of the Abu Dhabi Bone Marrow Transplant (AD-BMT © ) program, the first comprehensive programme to provide autologous and allogeneic hematopoietic stem cells transplant (HSCT) for adult and paediatric patients in the UAE since 2020. As a Center of Excellence in Hematopoietic Stem Cell Transplantation accredited by the Department of Health – Abu Dhabi, ADSCC's holistic service model includes advanced research, clinical trials, translational care, and manufacturing capabilities. ADSCC has one of the region's most advanced and sophisticated research labs and a robust multidisciplinary hospital. It is the only center in the UAE to encompass a cell processing laboratory, a state-of-the-art apheresis unit, a stem cell collection unit, a Good Manufacturing Practice (GMP) laboratory, and dedicated multi-specialty outpatient clinics and inpatient wards. As the UAE's first and most experienced stem cell transplant center, ADSCC has received multiple prestigious recognitions and conducted strategic collaborations, solidifying its position as a center of excellence. In 2024, ADSCC received accreditation from the Foundation for the Accreditation of Cellular Therapy (FACT) for its cellular therapy processing laboratory, the first in UAE and one of only two in Middle East to receive this global accreditation.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mid East Info
06-08-2025
- Mid East Info
WHX Dubai and WHX Labs Dubai to combine in 2026 to form the world's largest healthcare event - Middle East Business News and Information
More than 270,000 professionals from 180 countries and over 4,800 exhibitors will come together in Dubai for one week to shape the industry The events take place from 9-13 February 2026, in two iconic locations – Dubai Exhibition Centre (DEC) and Dubai World Trade Centre (DWTC) – forming a city-wide event Together, WHX Dubai and WHX Labs Dubai will transform Dubai into a global hub for healthcare innovation and collaboration Dubai, United Arab Emirates, August 2025 : Informa has announced the launch of the world's largest healthcare event, following the decision to hold two flagship events simultaneously in 2026. From 9-13 February 2026, WHX Dubai (formerly Arab Health) and WHX Labs Dubai (previously Medlab Middle East) will bring together more than 270,000 healthcare leaders from 180 countries and over 4,800 exhibitors, transforming Dubai into a global healthcare hub and an incubator for medical advancement. For decades, these events have positioned Dubai at the centre of global healthcare discussions. Co-timed in 2026, under the patronage of the UAE Ministry of Health and Prevention, they will combine to create the world's largest healthcare event – a city-wide opportunity for dealmaking, networking and knowledge-sharing that addresses universal healthcare and laboratory challenges. WHX Dubai will be held from 9-12 February at Dubai Exhibition Centre (DEC) in Expo City Dubai, marking the first time in its 50-year history that the event will take place outside the Dubai World Trade Centre (DWTC). The show will attract an international audience and serve as a global platform for innovation, enabling exhibitors to showcase solutions across nine diverse product sectors, including medical devices, imaging and diagnostics, and healthcare infrastructure. The 50 th edition of the event, which took place earlier this year, generated a record-breaking $2.57 billion in business value, with each exhibitor experiencing an average impact of $2.14 million. WHX Dubai 2026 is set to advance global health with a forward-thinking programme that includes seven CME-accredited conferences and over 250 speakers. This edition will introduce four new certified boot camps and three dedicated stages: the Future X Stage for cutting-edge ideas; the Frontiers Stage, which will present the latest advancements in science, wellness, and life sciences; and the Visionary Stage, where global leaders will share insightful perspectives on investment, leadership, artificial intelligence, and ESG. As it celebrates its 25th anniversary in 2026, WHX Labs Dubai will be held from 10-13 February at DWTC. Under the banner of '25 Years of Laboratory Innovation: Uniting Communities for Better Health' , the event will showcase excellence in laboratories, diagnostics and precision medicine. Last year, the WHX Labs Dubai generated $621 million in business. It served as a platform connecting key buyers, government ministries, and decision-makers who are driving diagnostics-related innovation and investment in the Middle East. WHX Labs Dubai will highlight the latest advancements from across the medical lab ecosystem through eight product pillars. Additionally, the 25th Annual Laboratory Management and Medicine Congress will feature eight CME-accredited scientific conference tracks with 250 global thought leaders and laboratory specialists. Attendees can also engage in industry-defining conversations at the WHX Labs Roundtables and participate in two new clinician conferences: the Precision Health Global Forum and the Antimicrobial Resistance Leadership Global Summit. Solenne Singer, Senior Vice President at Informa Markets, said: 'WHX Dubai and WHX Labs Dubai are both well-established events with a proven track record of advancing knowledge and trade at both regional and global levels. We are delighted to host them concurrently to form the world's largest healthcare event, which will transform Dubai into a hub for the global healthcare ecosystem for five enlightening days. 'Dubai's unique position will enable bold ideas and breakthroughs to cross borders rapidly, accelerating the spread of solutions from one market to another while reinforcing the UAE's status as an international centre for healthcare transformation. By hosting the world's largest healthcare event, our attendees will make a significant contribution to future advances in medical excellence and innovation in the UAE and beyond.' About World Health Expo: World Health Expo (WHX) unifies Informa's healthcare events globally to enhance connection and collaboration under a single brand. By integrating each event within the Informa Markets Healthcare portfolio, WHX seeks to increase their influence, encouraging greater innovation, stronger connections, and transformative progress within the healthcare ecosystem. Born from the legacy of Arab Health, WHX Dubai is more than a meeting point; it's the catalyst for global investment, cross-border collaboration, and the next wave of healthcare innovation. As the world converges in Dubai, WHX becomes the stage where game-changing partnerships are forged and the future of healthcare is accelerated. This is where progress begins, and the world takes notice. WHX Labs Dubai is the region's leading platform for laboratory innovation, diagnostics, and scientific discovery. Bringing together global experts, suppliers, and healthcare professionals, it's where the future of lab technology is accelerated, and where the next breakthroughs in patient care begin. WHX Dubai will be held from 9-12 February at the Dubai Exhibition Centre (DEC) in Expo City Dubai. WHX Labs Dubai will be held from 10-13 February at DWTC.
Daily News Egypt
13-07-2025
- Daily News Egypt
Health Ministry denies claims of meningitis-related deaths among siblings
Egypt's Ministry of Health and Population on Sunday dismissed recent reports alleging the simultaneous deaths of four siblings from meningitis, describing the claims as 'unfounded and scientifically unsupported.' In an official statement, the ministry explained that meningitis is an inflammation of the membranes surrounding the brain and spinal cord, which can result from infections caused by bacteria, viruses, fungi, or parasites—or from non-infectious factors such as tumors, certain medications, surgeries, or trauma. The ministry stressed that Egypt has successfully controlled the infectious bacterial type of meningitis since 1989, reducing infection rates to just 0.02 cases per 100,000 people. It confirmed that no outbreaks of bacterial strains A or C have been reported among school students since 2016, attributing this progress to comprehensive vaccination campaigns and continuous disease surveillance. Egypt's surveillance system includes routine daily reporting from healthcare facilities, alongside advanced monitoring at 12 fever hospitals where cerebrospinal fluid samples are tested using WHO-accredited PCR techniques. The ministry also noted that immediate care is provided for suspected cases, including diagnosis, treatment, and preventive antibiotics for close contacts. To support these efforts, Egypt distributes around 6.5 million doses of the A&C meningitis vaccine annually to first-year students across all educational stages, in addition to 600,000 doses of the quadrivalent vaccine for travelers heading to high-risk regions. The national immunization schedule also covers vaccines against Haemophilus influenzae and tuberculosis-related meningitis. Refuting the viral rumor, the ministry emphasized that there is 'no medical basis' for claims that four siblings could die simultaneously from a contagious disease like meningitis. It described such an event as highly implausible, highlighting that immune responses differ from person to person and that other potential causes—such as chemical exposure or food poisoning—must be thoroughly investigated before drawing conclusions. The ministry concluded by urging the public to rely on official health statements and refrain from circulating unverified medical information that could lead to unnecessary public concern or panic.
CairoScene
14-06-2025
- CairoScene
Over 2.4 Million People Donated Blood in Egypt Over Five Years
Egypt's national blood transfusion services have undergone extensive upgrades over the past five years. Jun 14, 2025 According to a report by the Ministry of Health and Population, a total of 2,491,759 individuals donated blood through 28 centres nationwide between 2020 and 2025, with many first-time donors continuing as regular contributors. Over this period, Egypt's national blood transfusion services have undergone extensive upgrades, enhancing service quality, infrastructure, and workforce development across the country. These efforts were accompanied by the establishment of six plasma donation centres in Agouza, Abbassia, Dar El Salam, Tanta, Alexandria, and Minya, part of a broader push toward achieving self-sufficiency in plasma derivatives. The National Blood Transfusion Center has maintained international standards, holding accreditation from the AABB since 2014 and securing its fourth renewal in December 2022. Similarly, the Red Cell Reference Laboratory (RCRL) remains accredited by the Egyptian Accreditation Council, with its certification extended through 2028. In 2023, the fourth edition of Egypt's national blood transfusion standards was approved and distributed in both Arabic and English, developed in coordination with the World Health Organization. Technological upgrades have played a central role in the expansion. Advanced blood separation devices and x-ray machines have enabled the production of more than 2.47 million separated blood samples. Flash luminescence virus testing has been introduced in 98% of blood centres, and nucleic acid testing is now in use across all national blood services. As of March 2025, hospital-based blood banks have also adopted nucleic acid testing as part of a project supported by the World Bank, contributing to the testing of over 2.5 million samples at national centres and an additional 1.84 million in hospitals.
